New Product Briefs: Medtronic CRT-D; Syncardia Valve; Lombard AAA Graft
This article was originally published in The Gray Sheet
Medtronic is set for the U.S. launch of the Viva Quad XT and Viva Quad S cardiac resynchronization devices. Syncardia earns FDA approval for a new propriety valve set for its total artificial heart. Lombard earns Japanese approval for its AAA graft. Philips announces a unique case in Canada.